Par Pharmaceutical plans to redeem 7 3/8% notes due 2020 on Sept. 30

By Angela McDaniels

Tacoma, Wash., Sept. 21 – Par Pharmaceutical Cos., Inc. issued a conditional notice of redemption for its $490 million of outstanding 7 3/8% senior notes due 2020, according to an 8-K filing with the Securities and Exchange Commission.

The notes will be redeemed in full on Sept. 30 at par plus the applicable premium and accrued interest up to but excluding the redemption date.

The redemption is conditioned on the closing of Endo International plc’s acquisition of the company by Sept. 30.

Par and Endo are pharmaceutical companies based in Chestnut Ridge, N.Y., and Dublin, respectively.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.